Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ0,00
KB0,00
PKN65,1165,142,13
Msft-0,17
Nokia3,29053,2965-1,02
IBM0,08
Mercedes-Benz Group AG73,8573,870,39
PFE-0,11
29.03.2024 1:04:00
Indexy online
AD Index online
select
AD Index online
 

  • 28.03.2024 21:15:00
USANA Hlth Sci (USNA.K, NY Consolidated)
Poslední obchod Změna (%) Změna (USD) Objem obchodů (ks)
48,50 0,48 0,23 72 291
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 29.03.2024
Popis společnosti
Obecné informace
Název společnostiUSANA Health Sciences, Inc.
TickerUSNA
Kmenové akcie:Ordinary Shares
RICUSNA.K
ISIN-
Poslední známé roční výsledky30.12.2023
Poslední známé čtvrtletní výsledky30.12.2023
Počet zaměstnanců k 23.02.2024 1 800
Akcie v oběhu k 23.02.2024 19 240 514
MěnaUSD
Konstituent indexůS&P 600 Small Cap
Kontaktní informace
Ulice3838 W Parkway Blvd
MěstoSALT LAKE CITY
PSČ84120-6336
ZeměUnited States
Kontatní osoba 
Funkce kontaktní osoby 
Telefon18 019 547 100
Fax18019569486

Business Summary: USANA Health Sciences, Inc. is a global direct-selling, personal health and wellness company that develops and manufactures science-based nutritional and personal care products. The Company operates through one segment: Direct-selling. Its two geographic regions include Asia Pacific, and Americas and Europe. The Company’s product lines include USANA Nutritionals Optimizers, Essentials/CellSentials, foods, personal care, skin care, and all others. The USANA Nutritionals Optimizers consist of supplements designed to meet individual health and nutritional needs. The Essentials/CellSentials product line includes vitamin and mineral supplements that provide total body nutrition. Its food product line includes meal replacement shakes, snack bars, and other related products. It also offers products designed for prenatal, infant, and young-child age groups in China. It distributes products internationally through direct selling, which entails person-to-person marketing and selling of products.
Financial Summary: BRIEF: For the fiscal year ended 30 December 2023, USANA Health Sciences, Inc. revenues decreased 8% to $921M. Net income decreased 8% to $63.8M. Revenues reflect Greater China segment decrease of 5% to $475.1M, Americas and Europe segment decrease of 8% to $180.6M. Net income also reflects Interest expense increase of 36% to $262K (expense). Basic Earnings per Share excluding Extraordinary Items decreased from $3.60 to $3.31.
Odvětvová klasifikace
TRBC2009Personal Products
TRBC2012Special Foods & Wellbeing Products
RBSS2004Personal Products
MGINDUSTRYBiotechnology & Drugs
MGSECTORHealthcare
NAICSMedicinal and Botanical Manufacturing
NAICSPharmaceutical Preparation Manufacturing
NAICSToilet Preparation Manufacturing
NAICSResearch and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
NAICS2007Medicinal & Botanical Mfg
NAICS2007Pharmaceutical Preparation Mfg
NAICS2007Toilet Preparation Manufacturing
NAICS2007Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
NAICS1997Medicinal and Botanical Manufacturing
NAICS1997Pharmaceutical Preparation Manufacturing
NAICS1997Toilet Preparation Manufacturing
NAICS1997Research and Development in the Physical, Engineering, and Life Sciences
SICMedicinals And Botanicals
SICMedicinals And Botanicals
SICPharmaceutical Preparations
SICToilet Preparations
SICCommercial Physical Research



  • Poslední aktualizace: 29.03.2024
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Executive Chairman of the BoardKevin Guest6001.07.2023
Chief Executive OfficerJim Brown5401.07.2023
Chief Financial OfficerG. Hekking5302.05.201710.05.2011
Chief Operating OfficerWalter Noot57
Chief People OfficerPaul Jones5914.12.2012
Chief Communications and Marketing OfficerDaniel Macuga5301.01.2011
Chief Scientific OfficerRobert Sinnott59
Chief Legal Officer, General Counsel and Corporate SecretaryP. Joshua Foukas47
Chief Officer and Managing Director of ChinaBrent Neidig39
Chief Sales OfficerDavid Mulham6208.02.2017